ZXB-17868-20917
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 928 / CA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Moderna
-
2021-03-30
Registered in v-safe
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-16
-
2021-04-21
Dose 2 — Moderna
-
2021-04-21
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-28
- 2021-05-07
- 2021-05-14
- 2021-06-02
- 2021-07-21
- 2021-10-22
-
2022-04-21
Survey response — 12 months, dose 2MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Tested positive for covidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Moderna | |
| 2 | 2021-04-21 | Moderna |
Free text
Release 11 — 12 months, dose 2
Symptoms: Tested positive for covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release